Julie Gentile, MD

Professor of psychiatry at the Boonshoft School of Medicine, Wright State University. Project director for Ohio’s Coordinating Center of Excellence in Mental Illness & Intellectual Disability

Psychopharmacology for Patients With Intellectual Disability

September 1, 2017

Julie Gentile, MD and David Dixon, DO

Julie Gentile, MD Professor of psychiatry at the Boonshoft School of Medicine, Wright State University. Project director for Ohio’s Coordinating Center of Excellence in Mental Illness & Intellectual Disability. Dr. Gentile has disclosed that they have no relevant financial or other interests in any commercial companies pertaining to this educational activity. David Dixon, DO Clinical chief resident, Wright State University, Department of Psychiatry. Dr. Dixon has disclosed that they have no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Prescribing psychotropic medications in patients with intellectual disability (ID) requires certain nuances in approach that may be unfamiliar to some psychiatrists. In this article, we’ll discuss some aspects of assessment and treatment that you may find useful when you encounter and work with such patients.

Interviewing and Evaluating Patients With Intellectual Disability

September 1, 2017

Julie Gentile, MD

Psychotherapy is all about communicating, yet people with intellectual disability often have significant limitations in their communication skills, depending on their level of cognitive functioning. Is it possible for us to help these patients? If so, how? Julie Gentile, MD (www.juliegentile.com) has been looking at these questions for 20 years.